@NephJC Ah, 20% non-inferiority (same as RAVE ). Time for me to roll out the non-inferiority must read https://t.co/uEBHVQoHIB #nephjc https://t.co/8Ppq2l7e1S
@toates_19 @callin_bull see https://t.co/uEBHVQoHIB Yes, linguistic contortions, but graphic below helps? #noninferiority https://t.co/hcxZDihrs4
RT @hswapnil: & of course, my plug for his great, open, non-inferiority review Red arrow where this study lies https://t.co/t0RzzCphxg ht…
@NephroMD @KidneyBeast see for review of non-inferiority & margin: https://t.co/t0RzzCphxg and make up your mind rather than take their word
@LLALO @RogueRad no other option in this scenario except non-inferiority: https://t.co/bWHxdX3BJI
& of course, my plug for his great, open, non-inferiority review Red arrow where this study lies https://t.co/t0RzzCphxg https://t.co/vqOHQt7yJT
RT @AberdeenICUEdu: After journal club this morning here’s a link to a paper mentioned on understanding non-inferiority trials. https://t.…
RT @AberdeenICUEdu: After journal club this morning here’s a link to a paper mentioned on understanding non-inferiority trials. https://t.…
RT @AberdeenICUEdu: After journal club this morning here’s a link to a paper mentioned on understanding non-inferiority trials. https://t.…
After journal club this morning here’s a link to a paper mentioned on understanding non-inferiority trials. https://t.co/Elj4nc1xky
RT @hswapnil: For #NephJC #RheumJC prep tonight: check out this easy to read primer on #noninferiority: https://t.co/30MGRP1juT #openacess
RT @hswapnil: For #NephJC #RheumJC prep tonight: check out this easy to read primer on #noninferiority: https://t.co/30MGRP1juT #openacess
RT @hswapnil: For #NephJC #RheumJC prep tonight: check out this easy to read primer on #noninferiority: https://t.co/30MGRP1juT #openacess
For #NephJC #RheumJC prep tonight: check out this easy to read primer on #noninferiority: https://t.co/30MGRP1juT #openacess
A paper that makes clinical study design concept easy! Thanks for share. A must-read #fellow #medicalstudent https://t.co/JsD7e3k8eW
@RichardLehman1 seems it's 'non-inferiority not shown' but definitely not superior eg see https://t.co/uEBHVQoHIB https://t.co/5lwEHhSGHL
RT @hswapnil: @jmwoods87 @woollymammoth @GIMJClub @NEJM see https://t.co/c88Ib06ITf depends a lot on NI margin you choose https://t.co/dIeR…
RT @hswapnil: @jmwoods87 @woollymammoth @GIMJClub @NEJM see https://t.co/c88Ib06ITf depends a lot on NI margin you choose https://t.co/dIeR…
RT @hswapnil: @jmwoods87 @woollymammoth @GIMJClub @NEJM see https://t.co/c88Ib06ITf depends a lot on NI margin you choose https://t.co/dIeR…
@jmwoods87 @woollymammoth @GIMJClub @NEJM see https://t.co/c88Ib06ITf depends a lot on NI margin you choose https://t.co/dIeRSF61J8
RT @BCSurgeons: Changes in clinical practice should not be based on non-inferiority trials #IGSJC https://t.co/IdpfYsY0Io
RT @BCSurgeons: Changes in clinical practice should not be based on non-inferiority trials #IGSJC https://t.co/IdpfYsY0Io
RT @alrodg: @andrewswright @BCSurgeons Also, 'non-inferiority' may be a counter-intuitive concept... https://t.co/kD8p6PFJIR
@andrewswright @BCSurgeons Also, 'non-inferiority' may be a counter-intuitive concept... https://t.co/kD8p6PFJIR
@eraycollins @VinayPrasad82 @ShamMailankody Yes, this mandatory reading: https://t.co/nBeCLkEfli #noninferiority https://t.co/iHpQrMcMt8
RT @hswapnil: @Skepticscalpel (and again run this image from https://t.co/nBeCLkmDWI) https://t.co/kPHcCqJrLz
RT @hswapnil: Could earlier initiation of RRT in AKI be harmful? Opinion piece: https://t.co/nBeCLkmDWI (rebuttal will be from C Ronco!)
Could earlier initiation of RRT in AKI be harmful? Opinion piece: https://t.co/nBeCLkmDWI (rebuttal will be from C Ronco!)
@Skepticscalpel (and again run this image from https://t.co/nBeCLkmDWI) https://t.co/kPHcCqJrLz
RT @MedicalEvidence: Possible outcomes of a non-inferiority trial - Review via #Trials: https://t.co/HXv0cIE9aZ https://t.co/jdHMjOcXBA
RT @MedicalEvidence: Possible outcomes of a non-inferiority trial - Review via #Trials: https://t.co/HXv0cIE9aZ https://t.co/jdHMjOcXBA
Understanding non-inferiority - most viewed in #Trials 2015 from @jschumi & Janet Wittes: https://t.co/lnToyOeDWB MT @MedicalEvidence
RT @MedicalEvidence: Most viewed article in #Trials in 2015 - understanding non-inferiority with @jschumi & Janet Wittes: https://t.co/N8vi…
RT @MedicalEvidence: Most viewed article in #Trials in 2015 - understanding non-inferiority with @jschumi & Janet Wittes: https://t.co/N8vi…
Most viewed article in #Trials in 2015 - understanding non-inferiority with @jschumi & Janet Wittes: https://t.co/N8virScG7B
RT @MedicalEvidence: Possible outcomes of a non-inferiority trial - Review via #Trials: https://t.co/HXv0cIE9aZ https://t.co/jdHMjOcXBA
RT @MedicalEvidence: Possible outcomes of a non-inferiority trial - Review via #Trials: https://t.co/HXv0cIE9aZ https://t.co/jdHMjOcXBA
RT @MedicalEvidence: Possible outcomes of a non-inferiority trial - Review via #Trials: https://t.co/HXv0cIE9aZ https://t.co/jdHMjOcXBA
RT @MedicalEvidence: Possible outcomes of a non-inferiority trial - Review via #Trials: https://t.co/HXv0cIE9aZ https://t.co/jdHMjOcXBA
RT @MedicalEvidence: Possible outcomes of a non-inferiority trial - Review via #Trials: https://t.co/HXv0cIE9aZ https://t.co/jdHMjOcXBA
Possible outcomes of a non-inferiority trial - Review via #Trials: https://t.co/HXv0cIE9aZ https://t.co/jdHMjOcXBA
@jdimick1 that's the correct interpretation. The reference http://t.co/nBeCLkmDWI explains it nicely @Sam_Pannick @Skepticscalpel @PHLane
RT @hswapnil: @Skepticscalpel good time to mention this? http://t.co/nBeCLkEfli #noninferiority @PHLane http://t.co/dtbbuXfi8i
RT @hswapnil: @Skepticscalpel good time to mention this? http://t.co/nBeCLkEfli #noninferiority @PHLane http://t.co/dtbbuXfi8i
RT @hswapnil: @Skepticscalpel good time to mention this? http://t.co/nBeCLkEfli #noninferiority @PHLane http://t.co/dtbbuXfi8i
RT @hswapnil: @Skepticscalpel good time to mention this? http://t.co/nBeCLkEfli #noninferiority @PHLane http://t.co/dtbbuXfi8i
RT @hswapnil: @Skepticscalpel good time to mention this? http://t.co/nBeCLkEfli #noninferiority @PHLane http://t.co/dtbbuXfi8i
RT @hswapnil: @Skepticscalpel good time to mention this? http://t.co/nBeCLkEfli #noninferiority @PHLane http://t.co/dtbbuXfi8i
@Skepticscalpel good time to mention this? http://t.co/nBeCLkEfli #noninferiority @PHLane http://t.co/dtbbuXfi8i
RT @MedicalEvidence: Always in the most viewed lists in #Trials - over 65k views - understanding non-inferiority from @jschumi & J Wittes: …
Always in the most viewed lists in #Trials - over 65k views - understanding non-inferiority from @jschumi & J Wittes: http://t.co/2Ayzj8HYn3
@camilla_wong Sorry I missed #gerimedJC, but re:#noninferiority, this is a great read: http://t.co/nBeCLkEfli (#openaccess)
@camilla_wong Sorry I missed #gerimedJC, but re:#noninferiority, this is a great read: http://t.co/nBeCLkEfli (#openaccess)
@camilla_wong and the results would align with red arrow (mod from same article) #GerimedJC http://t.co/nBeCLkEfli http://t.co/ntRlC1TUY5
@camilla_wong and the results would align with red arrow (mod from same article) #GerimedJC http://t.co/nBeCLkEfli http://t.co/ntRlC1TUY5
@camilla_wong and the results would align with red arrow (mod from same article) #GerimedJC http://t.co/nBeCLkEfli http://t.co/ntRlC1TUY5
@camilla_wong Sorry I missed #gerimedJC, but re:#noninferiority, this is a great read: http://t.co/nBeCLkEfli (#openaccess)
@VA_Boston_CMRs @ttphus this paper from @BioMedCentral is very useful IMO: http://t.co/nBeCLkEfli (#openaccess) http://t.co/8tWNjueSGe
@VA_Boston_CMRs @ttphus this paper from @BioMedCentral is very useful IMO: http://t.co/nBeCLkEfli (#openaccess) http://t.co/8tWNjueSGe
@ARD_BMJ @JAMA_current Much prefer this one: longer, more explanatory + #openaccess http://t.co/nBeCLkmDWI #noninferiority @BioMedCentral
@ARD_BMJ @JAMA_current Much prefer this one: longer, more explanatory + #openaccess http://t.co/nBeCLkmDWI #noninferiority @BioMedCentral
Through the looking glass: understanding non-inferiority http://t.co/dlpndBQXlq
@Skepticscalpel @buckeyesurgeon Nice. Re: the non-inferiority Orwellian crack, this may help http://t.co/c88Ib0ojKN http://t.co/UdNab5vNi7
@Skepticscalpel @buckeyesurgeon Nice. Re: the non-inferiority Orwellian crack, this may help http://t.co/c88Ib0ojKN http://t.co/UdNab5vNi7
Very nice review of understanding non-inferiority trials via @JohnGreenwoodMD http://t.co/tzkaCQ8Ix2 http://t.co/5TQoIEkIZi
Very nice review of understanding non-inferiority trials via @JohnGreenwoodMD http://t.co/tzkaCQ8Ix2 http://t.co/5TQoIEkIZi
Very nice review of understanding non-inferiority trials via @JohnGreenwoodMD http://t.co/tzkaCQ8Ix2 http://t.co/5TQoIEkIZi
Very nice review of understanding non-inferiority trials via @JohnGreenwoodMD http://t.co/tzkaCQ8Ix2 http://t.co/5TQoIEkIZi
Very nice review of understanding non-inferiority trials via @JohnGreenwoodMD http://t.co/tzkaCQ8Ix2 http://t.co/5TQoIEkIZi
Very nice review of understanding non-inferiority trials via @JohnGreenwoodMD http://t.co/tzkaCQ8Ix2 http://t.co/5TQoIEkIZi
Very nice review of understanding non-inferiority trials via @JohnGreenwoodMD http://t.co/tzkaCQ8Ix2 http://t.co/5TQoIEkIZi
Very nice review of understanding non-inferiority trials via @JohnGreenwoodMD http://t.co/tzkaCQ8Ix2 http://t.co/5TQoIEkIZi
Very nice review of understanding non-inferiority trials via @JohnGreenwoodMD http://t.co/tzkaCQ8Ix2 http://t.co/5TQoIEkIZi
Very nice review of understanding non-inferiority trials via @JohnGreenwoodMD http://t.co/tzkaCQ8Ix2 http://t.co/5TQoIEkIZi
Very nice review of understanding non-inferiority trials via @JohnGreenwoodMD http://t.co/tzkaCQ8Ix2 http://t.co/5TQoIEkIZi
Trying to make heads or tails of all the recent non-inferiority trials? http://t.co/AO5ymElPPe #FOAMed
Trying to make heads or tails of all the recent non-inferiority trials? http://t.co/AO5ymElPPe #FOAMed
Trying to make heads or tails of all the recent non-inferiority trials? http://t.co/AO5ymElPPe #FOAMed
Trying to make heads or tails of all the recent non-inferiority trials? http://t.co/AO5ymElPPe #FOAMed
Through the looking glass: understanding non-inferiority http://t.co/lYqcZuocco
Through the looking glass: understanding non-inferiority http://t.co/y8QODJ6odl
"Through the looking glass, understanding non-inferiority"- 61,000 accesses makes it the most viewed ever in #Trials: http://t.co/04ou44Py1N
Great review of #noninferiority trials and how differ from superiority/equivalency cousins. Double negatives abound! http://t.co/nOvTpf9gpd
@signindoc @purdy_eve #noninferiority! Time to roll out this figure from http://t.co/NXEWKQside from @BioMedCentral http://t.co/1ZglxhC8bK
@signindoc @purdy_eve #noninferiority! Time to roll out this figure from http://t.co/NXEWKQside from @BioMedCentral http://t.co/1ZglxhC8bK
@signindoc @purdy_eve #noninferiority! Time to roll out this figure from http://t.co/NXEWKQside from @BioMedCentral http://t.co/1ZglxhC8bK
@signindoc @purdy_eve #noninferiority! Time to roll out this figure from http://t.co/NXEWKQside from @BioMedCentral http://t.co/1ZglxhC8bK
@signindoc @purdy_eve #noninferiority! Time to roll out this figure from http://t.co/NXEWKQside from @BioMedCentral http://t.co/1ZglxhC8bK
Most viewed #Trials article over last 30 days - Through the looking glass, understanding non-inferiority: http://t.co/p7uVL59hv6
@DamianFog FWIW the actual paper does lay it out nicely: http://t.co/6C8qPcLP1d highly recommended read!
@CMichaelGibson citation: http://t.co/6C8qPcLP1d for non-inferiority http://t.co/qwlQ9WjBR0
. @kidney_boy @gastromom @NEJM This is why it is necessary, from http://t.co/6C8qPcLP1d non-inferiority is difficult http://t.co/0KUDrZNpd7